The SARS-CoV-2 Omicron variant evades vaccine-induced immunity. While a booster dose
of ancestral mRNA vaccines effectively elicits neutralizing antibodies against variants, its …

In light of the ongoing pandemic, development of vaccines to protect against SARS-CoV-2
infection and COVID-19 disease is an important public health priority. As of February 2021, …

Global deployment of vaccines that can provide protection across several age groups is still
urgently needed to end the COVID-19 pandemic, especially in low- and middle-income …

Global deployment of vaccines that can provide protection across several age groups is still
urgently needed to end the COVID-19 pandemic especially for low- and middle-income …

Activation of the innate immune system via pattern recognition receptors (PRRs) is key to
generate lasting adaptive immunity. PRRs detect unique chemical patterns associated with …

Adjuvants enhance vaccine immunogenicity and can be associated with reactogenicity.
Novel multidisciplinary approaches hold promise to accelerate and de-risk targeted adjuvant …

Background Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive
inflammatory disease caused by loss-of-function mutations in both alleles of the ADA2 gene. …

The US Centers for Disease Control and Prevention (CDC) and other health agencies have
recently recommended a booster dose of COVID-19 vaccines for specific vulnerable groups …

Older adults, defined as those ≥60 years of age, are a growing population vulnerable to
infections including severe acute respiratory syndrome coronavirus 2. Although immunization is …

The aim of this study is to investigate the utility of several biomarkers in differentiating bacterial
community-acquired lower respiratory tract infection (CA-LRTI) from non-bacterial CA-…